KLOW80 (BPC-157 (10 mg) + GHK-Cu (50 mg) + TB-500 (10 mg) + KPV (10 mg)) 80 mg Research Peptide Vial

Main Title

KLOW80 (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg) 80 mg — Advanced Tissue Repair & Recovery Research Blend

Full Description

KLOW80 is a research-grade synergistic peptide blend combining four well-studied compounds: BPC-157, GHK-Cu, TB-500, and KPV. This formulation is investigated in preclinical settings for its potential to support comprehensive tissue repair, modulate inflammation, promote angiogenesis, and enhance recovery processes across musculoskeletal, gastrointestinal, dermal, and systemic injury models.

What It Is

• Class: Multi-peptide tissue repair and cytoprotective research blend

• Concept: Combines complementary mechanisms targeting different aspects of healing — cytoprotection, actin regulation, extracellular matrix remodeling, and inflammation resolution — for synergistic effects in preclinical recovery research.

• Format: Research-grade lyophilized peptide blend supplied as a single vial.

Proposed Mechanisms (Preclinical)

Tissue Repair & Regeneration

• BPC-157 and TB-500 support angiogenesis, fibroblast activity, collagen organization, and cell migration via distinct pathways (VEGF, actin-binding).

• GHK-Cu promotes collagen synthesis, extracellular matrix remodeling, and stem cell recruitment.

Anti-Inflammatory & Cytoprotective Effects

• KPV inhibits NF-κB and pro-inflammatory cytokine release.

• BPC-157 and GHK-Cu provide broad organoprotective and antioxidant support in injury and stress models.

Synergistic Recovery Pathways

• The combination is explored for accelerated wound closure, improved tensile strength, reduced scarring, and enhanced functional recovery across multiple tissue types.

Selected Research Highlights

• Musculoskeletal Healing: Individual components have been studied for accelerated repair of tendons, ligaments, muscles, and bones in injury models.

• Gastrointestinal & Mucosal Repair: BPC-157 and KPV extensively investigated for IBD, ulcer, and intestinal barrier protection models.

• Dermal & Wound Healing: GHK-Cu and TB-500 researched for enhanced collagen quality, re-epithelialization, and reduced scarring in wound models.

• Angiogenesis & Vascular Support: TB-500 and GHK-Cu studied for new blood vessel formation and improved tissue perfusion.

• Anti-Inflammatory Synergy: KPV combined with BPC-157 explored for potent resolution of inflammation while supporting repair.

• Systemic Recovery: The blend approach is of interest in preclinical models requiring multi-pathway support for comprehensive healing.

Chemical & Handling Information

• Type: Synthetic peptide blend

• Composition: BPC-157 (10 mg) + GHK-Cu (50 mg) + TB-500 (10 mg) + KPV (10 mg)

• Appearance: White to off-white lyophilized powder

Specifications

• Peptide: KLOW80 Research Blend

• Amount: 80 mg per vial (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg)

• Form: Lyophilized powder

• Purity: ≥99% (HPLC) per individual peptide – Certificate of Analysis available per lot

• Packaging: Sealed vials suitable for standard laboratory handling

Storage & Stability

• Store lyophilized vials in a cool, dry place protected from light.

• Refrigeration or freezing of the lyophilized peptide is recommended for extended stability according to laboratory SOPs.

• After reconstitution: Store at 2–8 °C for short-term use.

• Long-term storage: Aliquot and freeze at –20 °C or below. Avoid repeated freeze-thaw cycles.